| Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial PG Gibson, IA Yang, JW Upham, PN Reynolds, S Hodge, AL James, ... The Lancet 390 (10095), 659-668, 2017 | 637 | 2017 |
| Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology SL Taylor, LEX Leong, JM Choo, S Wesselingh, IA Yang, JW Upham, ... Journal of Allergy and Clinical Immunology 141 (1), 94-103. e15, 2018 | 298 | 2018 |
| Long-Term Azithromycin Reduces Haemophilus influenzae and Increases Antibiotic Resistance in Severe Asthma SL Taylor, LEX Leong, FM Mobegi, JM Choo, S Wesselingh, IA Yang, ... American journal of respiratory and critical care medicine, 2019 | 162 | 2019 |
| Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis JD Chalmers, W Boersma, M Lonergan, L Jayaram, ML Crichton, ... The lancet Respiratory medicine 7 (10), 845-854, 2019 | 123 | 2019 |
| Matrix metalloproteinases vary with airway microbiota composition and lung function in non–cystic fibrosis bronchiectasis SL Taylor, GB Rogers, ACH Chen, LD Burr, MA McGuckin, DJ Serisier Annals of the American Thoracic Society 12 (5), 701-707, 2015 | 96 | 2015 |
| Neutrophils in asthma: the good, the bad and the bacteria H Crisford, E Sapey, GB Rogers, S Taylor, P Nagakumar, R Lokwani, ... Thorax 76 (8), 835-844, 2021 | 74 | 2021 |
| Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease C Rigauts, J Aizawa, SL Taylor, GB Rogers, M Govaerts, P Cos, L Ostyn, ... European Respiratory Journal 59 (5), 2022 | 73 | 2022 |
| Infection’s sweet tooth: How glycans mediate infection and disease susceptibility SL Taylor, MA McGuckin, S Wesselingh, GB Rogers Trends in microbiology 26 (2), 92-101, 2018 | 56 | 2018 |
| Host‐microbiome interactions in acute and chronic respiratory infections SL Taylor, S Wesselingh, GB Rogers Cellular microbiology 18 (5), 652-662, 2016 | 55 | 2016 |
| The impact of CFTR modulator therapies on CF airway microbiology GB Rogers, SL Taylor, LR Hoffman, LD Burr Journal of Cystic Fibrosis 19 (3), 359-364, 2020 | 49 | 2020 |
| Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non–Cystic Fibrosis Bronchiectasis. An Analysis from the Bronchiectasis and Low … LD Burr, GB Rogers, ACH Chen, BR Hamilton, GF Pool, SL Taylor, ... Annals of the American Thoracic Society 13 (10), 1697-1703, 2016 | 40 | 2016 |
| FUT2 genotype influences lung function, exacerbation frequency and airway microbiota in non-CF bronchiectasis SL Taylor, RJ Woodman, ACH Chen, LD Burr, DL Gordon, MA McGuckin, ... Thorax 72 (4), 304-310, 2017 | 38 | 2017 |
| Impact of long-term erythromycin therapy on the oropharyngeal microbiome and resistance gene reservoir in non-cystic fibrosis bronchiectasis JM Choo, GCJ Abell, R Thomson, L Morgan, G Waterer, DL Gordon, ... Msphere 3 (2), 10.1128/msphere. 00103-18, 2018 | 36 | 2018 |
| Airway abundance of Haemophilus influenzae predicts response to azithromycin in adults with persistent uncontrolled asthma SL Taylor, KL Ivey, PG Gibson, JL Simpson, GB Rogers, ... European Respiratory Journal 56 (4), 2020 | 35 | 2020 |
| Add-on azithromycin reduces sputum cytokines in non-eosinophilic asthma: an AMAZES substudy SD Shukla, SL Taylor, PG Gibson, D Barker, JW Upham, IA Yang, ... Thorax, 2021 | 20 | 2021 |
| The effects of increasing fruit and vegetable intake in children with asthma: A randomized controlled trial BS Berthon, RF McLoughlin, ME Jensen, B Hosseini, EJ Williams, ... Clinical & Experimental Allergy 51 (9), 1144-1156, 2021 | 16 | 2021 |
| Understanding the impact of antibiotic therapies on the respiratory tract resistome: a novel pooled-template metagenomic sequencing strategy SL Taylor, LEX Leong, FM Mobegi, JM Choo, LD Burr, S Wesselingh, ... Multidisciplinary respiratory medicine 13, 9-14, 2018 | 16 | 2018 |
| Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome LE Papanicolas, SK Sims, SL Taylor, SJ Miller, CS Karapetis, ... BMC cancer 21 (1), 591, 2021 | 14 | 2021 |
| Total bacterial load, inflammation, and structural lung disease in paediatric cystic fibrosis SL Taylor, LEX Leong, KL Ivey, S Wesselingh, K Grimwood, ... Journal of Cystic Fibrosis 19 (6), 923-930, 2020 | 14 | 2020 |
| Intestinal microbiota composition in sudden infant death syndrome and age-matched controls LEX Leong, SL Taylor, A Shivasami, PN Goldwater, GB Rogers The Journal of Pediatrics 191, 63-68. e1, 2017 | 14 | 2017 |
Geraint B RogersDirector of Microbiome Research, SAHMRI Infection and Immunity Theme, Flinders University, AdelaideVerified email at sahmri.com
